FeesSafety
Pluang+

Wolverine World Wide posts slight Q3 sales beat with strong brand momentum and tariff refund boost.

Company Fundamentals
16 Nov 2026, 20:46 WIB
Seeking Alpha
View Source
Bullish
Wolverine World Wide posts slight Q3 sales beat with strong brand momentum and tariff refund boost.

Wolverine World Wide, Inc. reported a slight beat on sales in Q3, driven by strong momentum from its largest brands like Saucony, which gained market share in running shoes. The company showed very strong profitability, partly due to a temporary boost from tariff refunds. The stock is currently fairly valued at an estimated worth of $24.50. This performance highlights the company's solid market position and potential stability in earnings moving forward.

Wolverine World Wide's Saucony brand growth is the subject, with Pluang's Consumer Cyclical sector data providing market context. Of 134 priced stocks in this sector, 39 rose and 95 fell as of Nov 17, 2026 01:02 WIB. Notable movers include VSXY at USD 101.17 with a -4.71% change and a typical hold time of 35 days, and NIO at USD 2.77 with a -4.66% change and a typical hold time of 83 days.

More News

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney's fiscal Q4 report, due November 17, is expected to show strong growth with analysts forecasting over 50% earnings per share (EPS) growth and more than 12% revenue increase. Streaming revenue rose 11% last quarter with margins hitting double d...

Company Fundamentals
Bullish
1 hour ago
Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox has launched a new Australia realm on Amazon Web Services (AWS) in the Sydney region, providing Australian government agencies and enterprises a local option for managing DNS, DHCP, and IP address management (DDI) with enhanced security. Thi...

Market News
Bullish
1 hour ago
European Commission approves RASONQUE for metastatic pancreatic cancer treatment

European Commission approves RASONQUE for metastatic pancreatic cancer treatment

The European Commission has approved RASONQUE (daraxonrasib), the first broad RAS-targeted oral medicine for adults with metastatic pancreatic adenocarcinoma who have had prior systemic therapy. This approval covers patients with or without identifie...

Market News
Bullish
2 hours ago
SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE, a European leader in multi-technical services, has acquired Dutch company Duflex B.V. to enhance its industrial automation, machine building, and robotics capabilities. Duflex, with 26 employees and €8 million revenue in 2025, specializes in ta...

Company Fundamentals
Bullish
3 hours ago
Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel Développement SAS disclosed that it repurchased a total of 3,878 of its own shares between November 9 and November 13, 2026. The average purchase price during this period was approximately €34.67 per share. This buyback is part of an authorized...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App